Ceribell earns Medicare win for brain monitoring tech
August 3, 2026
Ceribell (Nasdaq:CBLL) announced today that CMS granted a New Technology Add-on Payment (NTAP) for its Delirium Monitor System.
Ceribell (Nasdaq:CBLL) announced today that CMS granted a New Technology Add-on Payment (NTAP) for its Delirium Monitor System.
GE HealthCare (Nasdaq:GEHC) announced today that it launched its new Invenia ABUS Prime and ABUS StreamVue platforms.
enVVeno Medical (Nasdaq:NVNO) announced today that it received FDA investigational device exemption (IDE) for its enVVe system.
New medium-cutoff Dialyzer with a Super High-flux membrane brings NIPRO’s approach to expanded hemodialysis to United States healthcare providers.
Total Flow Medical announced today that it received FDA 510(k) clearance for its TFA femoral arterial cannula device.
Medical Microinstruments (MMI) announced today that the FDA approved a supplement to a study of its surgical robot in Alzheimer’s.
CorVista’s AI-based pulmonary capillary wedge pressure add-on test represents the third FDA clearance for its cardiopulmonary platform.
Saber-C AVIA is a zero-profile construct providing biomechanical stability similar to that of traditional plate systems.
Smith+Nephew (NYSE:SNN) announced today that the FDA granted de novo clearance for its TESSA spatial surgery system.
The PicoPretty device seamlessly integrates Picosecond, Long Pulse, and Genesis technologies to provide unparalleled versatility